Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vial, packaged in 3...

FDA Drug Recall #D-0178-2023 — Class II — January 12, 2023

Recall Summary

Recall Number D-0178-2023
Classification Class II — Moderate risk
Date Initiated January 12, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Nephron Sc Inc
Location West Columbia, SC
Product Type Drugs
Quantity 389,730 vials

Product Description

Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vial, packaged in 30 x 5 mL Single-Dose Vials per carton, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th Street Extension, W. Columbia, SC 29172, NDC 0487-6105-01, UPC 3 04876 10501 3.

Reason for Recall

CGMP Deviations: potential for trace amounts of product carryover.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lots: 124081, 124082, Exp. 04/2023; 224031, Exp. 01/2024

Other Recalls from Nephron Sc Inc

Recall # Classification Product Date
D-0364-2023 Class II Sterile Water for Injection, USP, 30x5 mL Singl... Feb 23, 2023
D-0176-2023 Class II S2 Racepinephrine Inhalation Solution, USP 2.25... Jan 13, 2023
D-0175-2023 Class II Asthmanefrin Racepinephrine Inhalation Solution... Jan 13, 2023
D-0177-2023 Class II 0.9% Sodium Chloride Injection, USP, 100 mL Sin... Jan 12, 2023
D-1354-2022 Class II Ketorolac Tromethamine Injection, USP 60 mg/2 m... Aug 10, 2022

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.